Multi-Arm Multi-StageMulti-Arm Multi-Stage (MAMS) trials have a specific design that allows for several different treatments to be evaluated simultaneously against the standard treatment in a single trial.
[mla_gallery meta_key="eupasset_name" meta_value="mams" columns="1" mla_caption="{+caption+}" link="file"(...)
MAMSMulti-Arm Multi-Stage (MAMS) trials have a specific design that allows for several different treatments to be evaluated simultaneously against the standard treatment in a single trial.
[mla_gallery meta_key="eupasset_name" meta_value="mams" columns="1" mla_caption="{+caption+}" link="file"(...)
MultiplicityMultiplicity occurs in clinical trials when a single clinical trial has several objectives, such as: assessing several different doses of a treatment, using several different endpoints to measure different aspects of a disease, or looking at several different subgroups of patients.Multiplicity(...)
MRPThe mutual recognition procedure is the system for medicines authorisation by individual member states (Concerned Member States) recognising the authorisation of another member state (the Reference Member State) which has evaluated and authorised a new medicine.
Mutual recognition procedureThe mutual recognition procedure is the system for medicines authorisation by individual member states (Concerned Member States) recognising the authorisation of another member state (the Reference Member State) which has evaluated and authorised a new medicine.
NCIPart of the US National Institutes of Health. http://www.cancer.gov/"
NCAA National Competent Authority – or regulatory authority – has the power to grant marketing authorisations for medicinal products in its territory.National competent authorities are organisations that have the legally delegated or invested authority, or power to perform a designated function,(...)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
